Estrogens, Conjugated (USP)

"Estrogens, Conjugated (USP)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.

Descriptor ID	D004966
MeSH Number(s)	D06.472.334.851.437.988
Concept/Terms	Estrogens, Conjugated (USP) Estrogens, Conjugated (USP) Estrogens, Conjugated Estrogenic Hormones, Conjugated Conjugated Estrogenic Hormones Conjugated Estrogens Estrogenic Substances, Conjugated Conjugated Estrogenic Substances Congest Congest Conjugated Equine Estrogens Conjugated Equine Estrogens Equine Estrogens, Conjugated Dagynil Dagynil Oestrofeminal Oestrofeminal Oestro-Feminal Oestro Feminal Estro-Feminal Estro Feminal Premarin Premarin Climopax Climarest Presomen Presomen Progens Progens Transannon Transannon Femavit Carentil Carentil Prelestrin Prelestrin

Below are MeSH descriptors whose meaning is more general than "Estrogens, Conjugated (USP)".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Gonadal Hormones [D06.472.334]
Gonadal Steroid Hormones [D06.472.334.851]
Estradiol Congeners [D06.472.334.851.437]
Estrogens, Conjugated (USP) [D06.472.334.851.437.988]

Below are MeSH descriptors whose meaning is related to "Estrogens, Conjugated (USP)".

Below are MeSH descriptors whose meaning is more specific than "Estrogens, Conjugated (USP)".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Estrogens, Conjugated (USP)" by people in this website by year, and whether "Estrogens, Conjugated (USP)" was a major or minor topic of these publications.

Bar chart showing 11 publications over 8 distinct years, with a maximum of 2 publications in 2002 and 2003 and 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	1	2
2003	1	1	2
2004	2	0	2
2006	1	0	1
2007	0	1	1
2008	0	1	1
2015	1	0	1
2020	1	0	1

Below are the most recent publications written about "Estrogens, Conjugated (USP)" by people in Profiles.

Armstrong NM, Espeland MA, Chen JC, Masaki K, Wactawski-Wende J, Li W, Gass MLS, Stefanick ML, Manson JE, Deal JA, Rapp SR, Lin FR, Resnick SM. Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women. J Gerontol A Biol Sci Med Sci. 2020 02 14; 75(3):537-544.

View in: PubMed
Espeland MA, Brinton RD, Manson JE, Yaffe K, Hugenschmidt C, Vaughan L, Craft S, Edwards BJ, Casanova R, Masaki K, Resnick SM. Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. Neurology. 2015 Sep 29; 85(13):1131-8.

View in: PubMed
Johnson KC, Margolis KL, Espeland MA, Colenda CC, Fillit H, Manson JE, Masaki KH, Mouton CP, Prineas R, Robinson JG, Wassertheil-Smoller S. A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study. J Am Geriatr Soc. 2008 Aug; 56(8):1449-58.

View in: PubMed
Diaby V, Perreault S, Lachaine J. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women. Maturitas. 2007 Oct 20; 58(2):138-49.

View in: PubMed
Hsia J, Criqui MH, Herrington DM, Manson JE, Wu L, Heckbert SR, Allison M, McDermott MM, Robinson J, Masaki K. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J. 2006 Jul; 152(1):170-6.

View in: PubMed
L?pez-Jaramillo P, D?az LA, Pardo A, Parra G, Jaimes H, Chaudhuri G. Estrogen therapy increases plasma concentrations of nitric oxide metabolites in postmenopausal women but increases flow-mediated vasodilation only in younger women. Fertil Steril. 2004 Dec; 82(6):1550-5.

View in: PubMed
Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004 Jun 23; 291(24):2947-58.

View in: PubMed
Hsia J, Criqui MH, Rodabough RJ, Langer RD, Resnick HE, Phillips LS, Allison M, Bonds DE, Masaki K, Caralis P, Kotchen JM. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative. Circulation. 2004 Feb 10; 109(5):620-6.

View in: PubMed
O'Connor KA, Brindle E, Holman DJ, Klein NA, Soules MR, Campbell KL, Kohen F, Munro CJ, Shofer JB, Lasley BL, Wood JW. Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem. 2003 Jul; 49(7):1139-48.

View in: PubMed
Katz S, Marshall J, Khorram O. An unusual case of ovarian resistance syndrome. Obstet Gynecol. 2003 May; 101(5 Pt 2):1078-82.

View in: PubMed

People

Explore

Similar Concepts

Top Journals